Synthesis and CNS activity of 1-alkyl-5-arylimidazolidine-2-thiones.
Matosiuk
D
D
Department of Medicines Technology, Faculty of Pharmacy, Medical School, Lublin, Poland.
Stefańczyk
J
J
Tkaczyński
T
T
D000818:Animals; D002491:Central Nervous System Agents / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D006591:Hexobarbital / Q000494:pharmacology; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007093:Imidazoles / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D012890:Sleep / Q000187:drug effects
D002491:Central Nervous System Agents; D006993:Hypnotics and Sedatives; D007093:Imidazoles; D006591:Hexobarbital